In this episode, we break down three of the most talked-about tools in metabolic health — Allulose, Metformin, and GLP-1 agonists (like Ozempic) — and explore how each impacts insulin resistance, glucose regulation, and metabolic health. We start with a clear overview of insulin resistance, then dive deep into the science of Allulose, how Metformin improves mitochondrial and hepatic function, and why GLP-1s can be both revolutionary and risky for long-term weight management and glucose control.

Whether you're a clinician, patient, or health enthusiast, this video will help you understand how these interventions work individually — and when each might be the right choice.

Chapters:

00:00 Intro

01:07 Summary of Insulin Resistance

02:59 Allulose Explained

17:05 How Metformin Works

22:57 Ideal Patients for Metformin vs GLP-1

26:25 What is a GLP-1 (Ozempic)?

30:28 Benefits and Risks of GLP-1s

38:47 Summary of GLP-1s

Key Topics Covered:

How insulin resistance develops and why it matters
Allulose’s role in lowering blood sugar and supporting fat metabolism
Metformin’s cellular mechanisms and benefits
GLP-1 agonists like Ozempic, Wegovy, and Mounjaro — how they work and potential long-term effects
Personalized medicine: choosing between Metformin and GLP-1s

#InsulinResistance #Metabolism #BloodSugar #Diabetes #Allulose #Metformin #GLP1 #Ozempic #WeightLoss #GlucoseControl #MetabolicHealth #Hormones #Nutrition #HealthEducation #Type2Diabetes